rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-1-3
|
pubmed:abstractText |
To assess the efficacy of phenylbutyrate (PB) in patients with spinal muscular atrophy in a randomized, double-blind, placebo-controlled trial involving 10 Italian centers.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1526-632X
|
pubmed:author |
pubmed-author:AngelozziCC,
pubmed-author:BattiniRR,
pubmed-author:BerardinelliAA,
pubmed-author:BertiniEE,
pubmed-author:BoffiPP,
pubmed-author:BraheCC,
pubmed-author:BrunoCC,
pubmed-author:CiniCC,
pubmed-author:ColittoFF,
pubmed-author:D'AmicoAA,
pubmed-author:KinaliMM,
pubmed-author:MercuriEE,
pubmed-author:MessinaSS,
pubmed-author:MinettiCC,
pubmed-author:MonginiTT,
pubmed-author:MorandiLL,
pubmed-author:MyouD SDS,
pubmed-author:NeriGG,
pubmed-author:OrcesiSS,
pubmed-author:PelliccioniMM,
pubmed-author:PiniAA,
pubmed-author:SolariAA,
pubmed-author:TizianoF DFD,
pubmed-author:VillanovaMM,
pubmed-author:VitaGG
|
pubmed:issnType |
Electronic
|
pubmed:day |
2
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-5
|
pubmed:meshHeading |
pubmed-meshheading:17082463-Child,
pubmed-meshheading:17082463-Child, Preschool,
pubmed-meshheading:17082463-Double-Blind Method,
pubmed-meshheading:17082463-Female,
pubmed-meshheading:17082463-Humans,
pubmed-meshheading:17082463-Male,
pubmed-meshheading:17082463-Muscular Atrophy, Spinal,
pubmed-meshheading:17082463-Phenylbutyrates,
pubmed-meshheading:17082463-Retrospective Studies
|
pubmed:year |
2007
|
pubmed:articleTitle |
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy.
|
pubmed:affiliation |
Department of Paediatric Neurology, Catholic University, Largo Gemelli, 00168 Rome, Italy. e.mercuri@imperial.ac.uk
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|